Erectile dysfunction drug protects the heart

A key ingredient in erectile dysfunction drugs can prevent remodelling of diseased hearts and improve cardiac performance, according to a study.

Phosphodiesterase type-5 inhibitors (PDE5i) have been found to exert an anti-remodelling effect on cardiac geometry for patients with moderate to severe left ventricular hypertrophy (LVH).

The effect is comparable with existing anti-remodelling drugs such as angiotensin